Verrica Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 1.12 M | $9.30 M | 75.05% | 11.79% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 707.34 K | $5.88 M | 100.00% | 7.45% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 471.56 K | $3.92 M | 100.00% | 4.97% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 353.67 K | $2.94 M | 100.00% | 3.73% |
| 02/13/2026 | 235.78 K | $1.96 B | 100.00% | 2.48% | |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 173.45 K | $1.44 M | 100.00% | 1.83% |
| VANGUARD GROUP INC | 01/29/2026 | 138.19 K | $1.15 M | -38.64% | 1.46% |
| JANE STREET GROUP, LLC | 02/12/2026 | 101.72 K | $845.31 M | 100.00% | 1.07% |
| MARSHALL WACE, LLP | 02/13/2026 | 85.17 K | $707.79 K | 100.00% | 0.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 67.66 K | $562.39 K | 0.00% | 0.71% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 44.43 K | $369.21 K | 100.00% | 0.47% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 33.27 K | $276.47 K | 100.00% | 0.35% |
| SOVRAN ADVISORS, LLC | 01/20/2026 | 32.66 K | $248.53 K | -55.75% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 26.40 K | $219.38 K | -9.56% | 0.28% |
| MARINER, LLC | 02/13/2026 | 24.54 K | $203.96 K | -0.02% | 0.26% |
| STATE STREET CORP | 02/13/2026 | 23.48 K | $195.13 K | 14.09% | 0.25% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 22.60 K | $187.81 K | 100.00% | 0.24% |
| MORGAN STANLEY | 02/13/2026 | 22.01 K | $182.89 K | 1.48% | 0.23% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 18.62 K | $154.74 K | 100.00% | 0.20% |
| HRT FINANCIAL LP | 02/12/2026 | 17.36 K | $144.00 K | 100.00% | 0.18% |
| LEGACY TRUST | 01/22/2026 | 17.23 K | $143.22 K | 100.00% | 0.18% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 15.24 K | $126.64 K | 100.00% | 0.16% |
| XTX TOPCO LTD | 02/17/2026 | 14.66 K | $121.84 M | 100.00% | 0.15% |
| BECK MACK & OLIVER LLC | 02/12/2026 | 12.00 K | $99.72 K | 100.00% | 0.13% |
| BLACKROCK, INC. | 02/12/2026 | 5.69 K | $47.24 M | -7.53% | 0.06% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 4.34 K | $36.09 M | 5,931.94% | 0.05% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 3.34 K | $27.77 K | 116.59% | 0.04% |
| CAPITAL ANALYSTS, LLC | 02/11/2026 | 1.50 K | $12.00 K | 0.00% | 0.02% |
| FORTITUDE FAMILY OFFICE, LLC | 01/15/2026 | 608 | $5.05 M | 100.00% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 416 | $3.00 K | -65.59% | 0.00% |
| SALOMON & LUDWIN, LLC | 01/28/2026 | 290 | $2.57 K | 0.00% | 0.00% |
| NEW ENGLAND CAPITAL FINANCIAL ADVISORS LLC | 02/02/2026 | 200 | $1.66 K | 0.00% | 0.00% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 02/03/2026 | 175 | $1.45 K | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 110 | $914 | -11.29% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/06/2026 | 102 | $847 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 47 | $391 | 100.00% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 24 | $199.00 K | -99.94% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 3 | $25 | 0.00% | 0.00% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 2 | $17 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 1 | $8 | 0.00% | 0.00% |
| FMR LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Verrica Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 53 institutional investors and hedge funds held shares of Verrica Pharmaceuticals Inc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.12 M
Affinity Asset Advisors, LLC: 707,338
Velan Capital Investment Management LP: 471,559
Stonepine Capital Management, LLC: 353,669
DAFNA Capital Management LLC: 173,451
VANGUARD GROUP INC: 138,194
25.66% of Verrica Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 4.75 M shares in the last 24 months. This purchase volume represents approximately $28.17 M in transactions.